[{"address1": "1500 District Avenue", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "617 600 7373", "website": "https://www.minervaneurosciences.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Remy  Luthringer Ph.D.", "age": 62, "title": "Executive Chairman & CEO", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1274649, "exercisedValue": 0, "unexercisedValue": 34200}, {"maxAge": 1, "name": "Mr. Geoffrey Robin Race F.C.M.A., M.B.A.", "age": 62, "title": "President", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 913302, "exercisedValue": 0, "unexercisedValue": 28880}, {"maxAge": 1, "name": "Mr. Frederick W. Ahlholm CPA", "age": 57, "title": "Senior VP, CFO & Secretary", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 726017, "exercisedValue": 0, "unexercisedValue": 19760}, {"maxAge": 1, "name": "Mr. Joseph  Reilly", "age": 48, "title": "Senior VP & COO", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 460999, "exercisedValue": 0, "unexercisedValue": 632717}, {"maxAge": 1, "name": "Mr. William B. Boni", "age": 71, "title": "Vice President of Investor Relations & Corporate Communications", "yearBorn": 1952, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Michael  Davidson M.D.", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 657466, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.36, "open": 3.42, "dayLow": 3.3101, "dayHigh": 3.42, "regularMarketPreviousClose": 3.36, "regularMarketOpen": 3.42, "regularMarketDayLow": 3.3101, "regularMarketDayHigh": 3.42, "beta": 0.134, "forwardPE": -0.9375, "volume": 5611, "regularMarketVolume": 5611, "averageVolume": 35821, "averageVolume10days": 23010, "averageDailyVolume10Day": 23010, "bid": 2.43, "ask": 4.35, "bidSize": 100, "askSize": 200, "marketCap": 23602758, "fiftyTwoWeekLow": 2.26, "fiftyTwoWeekHigh": 13.49, "fiftyDayAverage": 2.91058, "twoHundredDayAverage": 4.793555, "currency": "USD", "enterpriseValue": 73226344, "floatShares": 5436884, "sharesOutstanding": 6993410, "sharesShort": 14522, "sharesShortPriorMonth": 31674, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.0021, "heldPercentInsiders": 0.22257, "heldPercentInstitutions": 0.3032, "shortRatio": 0.21, "shortPercentOfFloat": 0.0037, "bookValue": -5.232, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -31603746, "trailingEps": -4.43, "forwardEps": -3.6, "enterpriseToEbitda": -2.995, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NERV", "underlyingSymbol": "NERV", "shortName": "Minerva Neurosciences, Inc", "longName": "Minerva Neurosciences, Inc.", "firstTradeDateEpochUtc": 1404221400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ceeb0642-b36f-3eda-bb3a-75cdc1b13e8a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.375, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 34818304, "totalCashPerShare": 4.979, "ebitda": -24447580, "totalDebt": 84267064, "quickRatio": 12.3, "currentRatio": 12.583, "returnOnAssets": -0.29936, "freeCashflow": -18346104, "operatingCashflow": -20763596, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-16"}]